15
PARP inhibitors as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer: can we afford it?
PARP inhibitors as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer: can we afford it?
Saturday, March 28, 2015: 2:43 PM
International Ballroom (Hilton Chicago)